Ionis Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +44.6% | -27.8% | -3.0% | +5.4% | +45.6% | -16.2% | -18.5% | +23.5% | +32.1% | +54.7% | -44.9% | +2.5% | +194.0% | -73.0% | +9.1% | +10.0% | +81.3% | -61.6% | +12.7% | +5.8% | +230.6% | -67.7% | -5.7% | +19.4% | -4.9% | -14.1% | +44.3% | -23.5% | -17.1% | +0.0% | +88.5% | -40.6% | +69.3% | -41.9% | +243.5% | -65.3% | +29.5% | +21.2% | +8.9% | – | |
| – | +19.5% | -18.3% | +1.1% | -3.9% | +59.9% | -18.9% | -2.1% | -6.5% | +21.0% | -99.1% | +31.0% | -29.1% | +4.6% | +152.0% | +18.2% | +2.5% | +7.0% | -21.9% | +14.7% | +4.1% | -27.7% | +87.3% | +13.8% | -68.1% | +143.3% | -63.6% | +88.9% | -13.6% | -1.8% | +0.0% | +93.6% | -74.3% | +257.6% | -60.8% | +176.7% | -43.7% | +242.2% | -62.7% | -8.2% | – | |
| – | +125.1% | -44.0% | -13.3% | +32.4% | +15.5% | +228.1% | -18.5% | +23.5% | -47.1% | +285.4% | -45.2% | +2.8% | +195.1% | -73.4% | +8.9% | +10.2% | +82.8% | -62.0% | +12.6% | +5.9% | +236.7% | -68.5% | -6.3% | +22.6% | -6.3% | -12.8% | +43.9% | -23.6% | -17.4% | +0.0% | +88.4% | -40.0% | +67.8% | -41.6% | +244.2% | -65.5% | +26.3% | +24.7% | +9.1% | – | |
| – | +19.5% | -18.3% | +1.1% | -3.9% | +59.9% | -18.9% | -2.1% | -6.5% | +19.1% | -6.2% | -0.4% | -1.5% | +42.8% | -21.5% | +4.5% | +2.3% | +36.7% | -18.2% | -0.4% | +32.6% | -3.1% | -10.0% | +12.2% | +1.2% | +68.3% | -35.7% | +16.2% | -6.5% | -0.4% | +0.0% | +3.7% | -1.0% | +11.7% | -18.2% | +8.3% | +0.1% | +28.6% | -24.9% | +3.3% | – | |
| – | +77.1% | -24.2% | +63.2% | +20.0% | +70.6% | -4.5% | +51.6% | +3.8% | -3.9% | +3.3% | +10.1% | -20.1% | +38.7% | -9.9% | -4.0% | -5.0% | +103.0% | -58.9% | -21.0% | -33.3% | +28.2% | -11.6% | -1.0% | +1.8% | +39.2% | -5.0% | +1.3% | +51.8% | -24.8% | +0.0% | +23.7% | -5.4% | +43.0% | -13.4% | +18.7% | +6.8% | +34.5% | +15.5% | +0.0% | – | |
| – | +77.1% | -24.2% | +63.2% | +20.0% | +70.6% | +223.2% | +13.7% | -2.4% | -59.7% | +164.4% | +3.8% | -9.3% | +41.1% | -17.3% | +1.2% | -0.4% | +60.0% | -35.1% | -2.6% | +10.3% | +0.6% | -10.1% | +9.9% | +1.3% | +63.9% | -31.7% | +13.5% | +3.3% | -6.5% | +0.0% | +7.6% | -2.0% | +18.5% | -17.0% | +11.2% | +2.1% | +30.3% | -12.1% | +1.9% | – | |
| – | +155.5% | -52.7% | -66.9% | +75.4% | -115.0% | – | – | – | – | +1,026.9% | -115.5% | – | +10,231.1% | -123.5% | – | – | – | – | – | – | – | -126.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | -214.6% | – | – | – | – | |
| – | +1.9% | +14.4% | +3.7% | -8.1% | -0.4% | +1.4% | +1.6% | +1.5% | +1.6% | +1.2% | +1.8% | +1.7% | +11.3% | -83.5% | +10.6% | -0.5% | +0.2% | -0.8% | -2.4% | -0.7% | -4.4% | -5.2% | +0.4% | +0.4% | -19.1% | +889.2% | +16.5% | +10.2% | +0.6% | +0.0% | +3.1% | -0.4% | +0.7% | +0.3% | -0.7% | -2.6% | +2.4% | -0.8% | -1.7% | – | |
| – | +291.8% | -68.9% | -131.9% | – | – | – | – | – | – | +1,032.5% | -113.9% | – | +6,674.6% | -122.2% | – | – | – | – | – | – | – | -128.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | -203.9% | – | – | – | – | |
| – | -69.9% | +238.4% | -97.8% | +332.9% | -845.5% | – | +2,286.7% | +26.3% | -64,694.0% | – | -122.3% | – | – | -109.0% | – | +143.0% | +6,175.3% | -100.0% | +151.5% | -499.7% | – | +261.1% | +106.6% | -87.5% | +2,762.2% | +40.5% | -31.1% | -15.8% | -98.9% | +0.0% | -14.7% | -5,757.8% | – | – | -117.2% | – | +369.5% | -78.2% | -679.8% | – | |
| – | +251.9% | -65.3% | -134.4% | – | – | -151.7% | – | – | – | -73.6% | -101.0% | – | +604.9% | -121.5% | – | – | – | – | – | – | – | -129.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | -204.1% | – | – | – | – | |
| – | +111.7% | -44.6% | -50.1% | -39.5% | -100.6% | – | -1,530.3% | – | – | +434.3% | -100.7% | – | +1,231.8% | -118.5% | – | – | – | – | – | – | – | -125.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | -168.8% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.